Stage IVA Uterine Corpus Carcinoma or Carcinosarcoma by AJCC v7 Stage
2 clinical trials · Condition
◉ Watch Stage IVA Uterine Corpus Carcinoma or Carcinosarcoma by AJCC v7 Stage
| Record | Firm | Date |
|---|---|---|
| Cabozantinib S-Malate in Treating Patients With Recurrent or Metastatic Endometrial Cancer (NCT01935934) | National Cancer Institute (NCI) | 2013-05-08 |
| Paclitaxel, Carboplatin, and Bevacizumab or Paclitaxel, Carboplatin, and Temsirolimus or Ixabepilone, Carboplatin, and Bevacizumab in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer (NCT00977574) | National Cancer Institute (NCI) | 2009-09-14 |
Track Stage IVA Uterine Corpus Carcinoma or Carcinosarcoma by AJCC v7 Stage automatically
Every clearance here is in the API, with alerts when new ones post.